Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The objective of this study was to investigate the bioequivalence of Mylan\'s ondansetron 24 mg tablets to GSK\'s Zofran® 24 mg tablets following a single, oral 24 mg (1 x 24 mg) dose administered under fasting conditions.
Epistemonikos ID: ea6610cc851c9fa67fb7ea9cce614971f81d8a2b
First added on: May 04, 2024